Robert Neville
2018
In 2018, Robert Neville earned a total compensation of $4.1M as Chief Executive Officer at Mast Therapeutics, a 586% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $225,750 |
|---|---|
| Option Awards | $3,342,724 |
| Salary | $525,000 |
| Other | $22,000 |
| Total | $4,115,474 |
Neville received $3.3M in option awards, accounting for 81% of the total pay in 2018.
Neville also received $225.8K in non-equity incentive plan, $525K in salary and $22K in other compensation.
Rankings
In 2018, Robert Neville's compensation ranked 2,685th out of 14,244 executives tracked by ExecPay. In other words, Neville earned more than 81.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,685 out of 14,244 | 81st |
Division Manufacturing | 996 out of 5,765 | 83rd |
Major group Chemicals And Allied Products | 345 out of 2,128 | 84th |
Industry group Drugs | 283 out of 1,817 | 84th |
Industry Pharmaceutical Preparations | 219 out of 1,391 | 84th |
Pay ratio
| Robert Neville's Pay | $4,115,474 |
|---|---|
| Median Employee's Pay | $282,179 |
| Pay Ratio | 15to 1 |
In 2018, the annual total compensation of Robert Neville was $4,115,474.
The annual total compensation of the median employee at Mast Therapeutics was $282,179.
The ratio of Robert Neville's pay to the pay of median employee was therefore 15 to one.
Source: SEC filing on April 15, 2019.
Neville's colleagues
We found three more compensation records of executives who worked with Robert Neville at Mast Therapeutics in 2018.